The most comprehensive genetic study to date of the blood cancer multiple myeloma has revealed that the genetic landscape of the disease may be more complicated than previously thought. Through results published in Cancer Cell, a team of Broad researchers, including scientists from Dana-Farber Cancer Institute, has shown that an individual patient’s tumor can harbor populations of cancer cells equipped with different mutations. Read more here.
Study mentioned: Lohr JG, et al. Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy. Cancer Cell. 2014 Jan 13;25(1):91-101. PMID: 24434212
No comments:
Post a Comment